Image Eye 01.png

In The Press

March 30, 2022

RetiSpec and retinal imaging in general, could have an extremely positive impact on the AD community, Sharon Cohen, MD, FRCPC, believes. Cohen, a neurologist and assistant professor at the University of Toronto, led the validation study of RetiSpec... 

March 25, 2022

Developments in non-invasive retinal imaging technologies, such as RetiSpec, have provided a means to study neuronal and vascular structures in the retina in people with AD. In a validation study, RetiSpec’s hyperspectral retinal imaging was effective... 

March 21, 2022

Sharon Cohen, MD, FRCPC, lead investigator of a validation study that looked at RetiSpec, believes these types of approaches hold immense potential in the drug development field. Despite the increasing amount of funds poured into the therapeutic... 

March 18, 2022

 RetiSpec’s hyperspectral retinal imaging system is adding to the promise of these approaches, most recently with positive data presented at the 14th Clinical Trials in Alzheimer Disease Conference, November 9-12, 2021. In a cohort of 108 participants...

March 14, 2022

Although investigational, lead author Sharon Cohen, MD, believes there is great potential for retinal approaches such as those being taken by RetiSpec. Cohen, a neurologist and assistant professor at the University of Toronto, sat down with...

March 14, 2022

At the 14th Clinical Trials on Alzheimer’s Disease Conference (CTAD), November 9-12, 2021, investigators presented research that demonstrated RetiSpec’s ability to predict brain amyloid status. In a cross-sectional validation study, 108 patients who... 

Feb 11, 2022

As attention turns to new drugs that can address the growing burden of Alzheimer’s disease (AD) in an aging global population, Retispec Inc. has developed a noninvasive test that may be able to detect early signs of the neurodegenerative...

Feb 3, 2022

Gentex Corporation is the presenting sponsor of this year's Michigan International Auto Show and they're also leaders when it comes to automotive technology. They're starting to take their automotive expertise into new markets as well...

Jan 5, 2022

To mark January as Alzheimer’s Awareness Month, we’re joined by Sharon Cohen, a neurologist who runs Canada’s busiest memory clinic, in Toronto... 

Dec 7, 2021

A huge benefit of RetiSpec and other early-detection tools is that they are inexpensive, non-invasive and quick. Currently, Alzheimer’s is diagnosed with lumbar punctures, cognitive tests and PET scans...

Nov 9, 2021

We’ve all heard the statistics: Today, nearly 55 million people suffer from Alzheimer’s disease or related dementias. According to the WHO, dementia is the fastest growing burden on healthcare systems...

Oct 29, 2021

The approval of Biogen’s Alzheimer’s treatment could herald a new generation of therapies, but before that can happen, more investment and better diagnostics may be needed, explains Ben Hargreaves...

Sept 21, 2021

Billionaire philanthropist speaks of the new breakthroughs in diagnostics that are being conducted through Diagnostic Accelerator, a venture that raises philanthropic capital for research in this field...

Sept 20, 2021

Gates Notes

New breakthroughs in Alzheimer’s diagnostics may someday soon let us substantially alter the course of the disease...

June 22, 2021

Dr. Karen Cross was doing everything in her power to prevent her diabetic grandfather from needing an amputation. But that power was limited by distance — Cross works in Toronto and her grandfather was in rural Newfoundland...

Apr 24, 2021

With disease-modifying treatments for Alzheimer’s disease potentially on the cusp of approval, there will be pressing demand for quick...

April 20, 2021

Washington, DC (April 20, 2021) – Today, the Global Alzheimer’s Platform Foundation® (GAP) announced eleven biopharma, technology, and nonprofit partners who are contributing to GAP’s Bio-Hermes Study...

Nov 21, 2020

Toronto-based biomedical engineers Eliav Shaked and Roy Kirshon are working on a quick, non-invasive retinal diagnostic for patients decades away from showing symptoms of dementia...

Oct 5, 2020

RetiSpec (Toronto, Canada) is an AI medical imaging company developing tools for the early detection of disease biomarkers in the eye.

RetiSpec's technology uses a device to perform a simple eye scan, which then can be used to identify the presence of certain disease biomarkers ...

Nov 11, 2019

“In collaboration with our industry partner, RetiSpec, we hope to accelerate clinical development of this early detection technique and provide existing or new treatments the best chance for success,” added Vince. This study was funded by the...

Oct 25, 2019

RetiSpec technology is hoped to be able to match this early detection ability without the shortcomings of the other approaches. Eliav Shaked, ...

Oct 08, 2019

Disruptive Technology Harnesses Hyperspectral Imagery and Machine-Learning to Allow for Rapid and Cost-Effective Identification of Alzheimer's Biomarkers ...

Oct 08, 2019

Could a simple eye exam detect signs of Alzheimer's disease?

Oct 14, 2019

RetiSpec's technology is designed to identify Alzheimer's biomarkers years before the emergence of clinical symptoms.

2019

A new intiative from the Toronto Memory Project is trying to use retina scans to determine if patient's have Alzheimer's disease

2018/19

CABHI is working with RetiSpec to accelerate its technology in Ontario and Canada. Through the Industry Innovation Partnership Program (I2 P2 ), CABHI matched RetiSpec with the Toronto Memory Program, a medical facility with one of...

 Oct 24, 2018

The University of Minnesota and Toronto-based medical imaging company RetiSpec have announced a collaboration and licensing

Oct 17, 2018

The collaboration provides RetiSpec, a startup based in Toronto, Canada, with exclusive access to an imaging system developed by researchers ...

June 22, 2016

University of Minnesota researchers have developed technology to detect early signs of Alzheimer's. Utilizing the non-invasive technology, researchers from the Center for Drug Design were able to visualize clear patterns of changes suggesting the...